Access cutting-edge breast cancer treatment through this clinical trial at a research site in Madison. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Madison at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This phase II trial studies the effect of DNA plasmid based vaccine (STEMVAC) in treating patients with patients with stage IB-III triple negative breast cancer. STEMVAC may wake up the immune system in patients who have had a diagnosis of triple negative breast cancer and have been treated. STEMVAC targets proteins that are expressed on breast cancer cells and works by boosting the immune system to recognize and destroy the invader cancer cell proteins that are causing the disease. The purpose
Sponsor: University of Washington
Check if you qualify for this breast cancer clinical trial in Madison, WI
If you're searching for breast cancer treatment options in Madison, WI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Madison research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.